These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 20383200

  • 1. Nodal promotes growth and invasion in human gliomas.
    Lee CC, Jan HJ, Lai JH, Ma HI, Hueng DY, Lee YC, Cheng YY, Liu LW, Wei HW, Lee HM.
    Oncogene; 2010 May 27; 29(21):3110-23. PubMed ID: 20383200
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS.
    J Cell Biochem; 2006 Sep 01; 99(1):156-67. PubMed ID: 16791855
    [Abstract] [Full Text] [Related]

  • 3. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
    Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J, Li M.
    Cancer Res; 2010 May 01; 70(9):3750-9. PubMed ID: 20388776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
    Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, Kim HS.
    Chem Biol Interact; 2010 Apr 15; 185(1):18-24. PubMed ID: 20188714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 12. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
    Johnson KJ, Peng KW, Allen C, Russell SJ, Galanis E.
    Gene Ther; 2003 May 15; 10(9):725-32. PubMed ID: 12704411
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y.
    Cancer Gene Ther; 2004 May 15; 11(5):325-32. PubMed ID: 15044958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H, Huang Q, Zhai DZ, Dong J, Wang AD, Lan Q.
    Zhonghua Zhong Liu Za Zhi; 2007 Jul 15; 29(7):484-8. PubMed ID: 18069625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
    Weiler M, Bähr O, Hohlweg U, Naumann U, Rieger J, Huang H, Tabatabai G, Krell HW, Ohgaki H, Weller M, Wick W.
    Cell Death Differ; 2006 Jul 15; 13(7):1156-69. PubMed ID: 16254573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.